Arocell Ab Stock Total Asset
| AROC Stock | SEK 0.40 0.03 6.98% |
AroCell AB fundamentals help investors to digest information that contributes to AroCell AB's financial success or failures. It also enables traders to predict the movement of AroCell Stock. The fundamental analysis module provides a way to measure AroCell AB's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to AroCell AB stock.
AroCell |
AroCell AB Company Total Asset Analysis
AroCell AB's Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Current AroCell AB Total Asset | 227.41 M |
Most of AroCell AB's fundamental indicators, such as Total Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, AroCell AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
| Competition |
Based on the latest financial disclosure, AroCell AB has a Total Asset of 227.41 M. This is 96.98% lower than that of the Life Sciences Tools & Services sector and 99.46% lower than that of the Health Care industry. The total asset for all Sweden stocks is 99.23% higher than that of the company.
AroCell Total Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses AroCell AB's direct or indirect competition against its Total Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of AroCell AB could also be used in its relative valuation, which is a method of valuing AroCell AB by comparing valuation metrics of similar companies.AroCell AB is currently under evaluation in total asset category among its peers.
AroCell Fundamentals
| Return On Equity | -0.26 | |||
| Return On Asset | -0.16 | |||
| Profit Margin | (2.04) % | |||
| Operating Margin | (2.07) % | |||
| Current Valuation | 63.02 M | |||
| Shares Outstanding | 230.36 M | |||
| Shares Owned By Insiders | 41.61 % | |||
| Price To Earning | (11.21) X | |||
| Price To Book | 0.55 X | |||
| Price To Sales | 4.05 X | |||
| Revenue | 12 M | |||
| Gross Profit | (5.04 M) | |||
| EBITDA | (45.23 M) | |||
| Net Income | (50.02 M) | |||
| Cash And Equivalents | 21.43 M | |||
| Cash Per Share | 0.52 X | |||
| Current Ratio | 10.33 X | |||
| Book Value Per Share | 1.04 X | |||
| Cash Flow From Operations | (28.21 M) | |||
| Earnings Per Share | (0.50) X | |||
| Target Price | 2.3 | |||
| Number Of Employees | 20 | |||
| Beta | 1.38 | |||
| Market Capitalization | 152.77 M | |||
| Total Asset | 227.41 M | |||
| Retained Earnings | (5 M) | |||
| Working Capital | 41 M | |||
| Current Asset | 44 M | |||
| Current Liabilities | 3 M | |||
| Net Asset | 227.41 M |
About AroCell AB Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze AroCell AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AroCell AB using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AroCell AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for AroCell Stock Analysis
When running AroCell AB's price analysis, check to measure AroCell AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AroCell AB is operating at the current time. Most of AroCell AB's value examination focuses on studying past and present price action to predict the probability of AroCell AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AroCell AB's price. Additionally, you may evaluate how the addition of AroCell AB to your portfolios can decrease your overall portfolio volatility.